You may have a claim if: You used Ozempic, Wegovy, Rybelsus, Trulicity, or Mounjaro for diabetes management or weight loss You developed severe gastrointestinal problems during or after your treatment, including gastroparesis, ileus, intestinal obstruction, or persistent severe nausea and vomiting You have objective medical testing documenting your condition, such as gastric emptying studies, imaging showing delayed gastric emptying, or other diagnostic tests You required medical intervention, including hospitalization, medications to manage symptoms, dietary changes, or surgical procedures Your states statute of limitations hasnt expired for your potential claim At Ferrer Poirot Feller, well work with you to gather your medical records, review your diagnostic tests, and evaluate whether you have a viable claim
When mixed with water or juice the taste can be mild.* Q
Kovatch, P
A clear example of non-retained compounds in RPLC includes the buffering and tonicity agents commonly found in liquid formulations of GLP-1 RAs, such as sodium chloride, sodium phosphate, both present in top -selling drugs Mounjaro (tirzepatide) and Ozempic
"//" separates results from different trials) Wegovy (Semaglutide)- 14.9% over 68 weeks Mounjaro/ZepBound (Tirzeptide)- 15-21% // 25% over 72-88 weeks Retatrutide- 24.2% // 28% to 30% over 48 to 68+ weeks First, it should be noted that they are all very effective
